HIGH GRADE SEROUS OVARIAN CARCINOMA
Clinical trials for HIGH GRADE SEROUS OVARIAN CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HIGH GRADE SEROUS OVARIAN CARCINOMA trials appear
Sign up with your email to follow new studies for HIGH GRADE SEROUS OVARIAN CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to shrink recurrent ovarian tumors
Disease control Not yet recruitingThis phase II trial tests an experimental drug called SYS6041, alone or combined with chemotherapy and other agents, in women whose ovarian cancer has returned. The study evaluates safety, the best dose, and how well the treatments shrink tumors. Participants must have a specific…
Matched conditions: HIGH GRADE SEROUS OVARIAN CARCINOMA
Phase: PHASE2 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New drug combo aims to improve ovarian cancer maintenance with fewer dropouts
Disease control Not yet recruitingThis trial tests whether fluzoparib plus bevacizumab works as well as the standard olaparib plus bevacizumab for maintenance therapy in women with HRD-positive advanced ovarian cancer after initial chemotherapy. The study enrolls about 120 participants and tracks how long they st…
Matched conditions: HIGH GRADE SEROUS OVARIAN CARCINOMA
Phase: PHASE2 • Sponsor: Shandong University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC